Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2010
03/24/2010CN101678017A Method of treating diabetes
03/24/2010CN101678013A piperidine/piperazine derivatives
03/24/2010CN101677982A Combination therapy, composition and methods for the treatment of cardiovascular disorders
03/24/2010CN101677958A Oral pharmaceutical preparation for colon-specific delivery
03/24/2010CN101677932A Skin-lightening agent containing equol compound as active ingredient
03/24/2010CN101677601A Cereal-based infant nutrition with fibre
03/24/2010CN101677597A Tympanites ventriculi-controlling agent for ruminant animals
03/24/2010CN101677596A Lumen fermentation improving agent
03/24/2010CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands
03/24/2010CN101676281A Benzo macrolide compound (3R)- des-O-methyllasiodiplodin, its derivatives and preparation method and use
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN101675971A A formula of a traditional Chinese medicine preparation and preparation technology thereof
03/24/2010CN101675970A Pure traditional Chinese medicine preparation for treating diabetes
03/24/2010CN101675950A A traditional Chinese medicine preparation for treating diabetic nephropathy, and preparation method and application thereof
03/24/2010CN101675949A A monkshood formula for treating diabetes
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675929A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100595204C Bisamidate phosphonate prodrugs
03/24/2010CN100594933C Antiobestic agents and health foods
03/24/2010CN100594929C Oral insulin medicine and preparation method thereof
03/24/2010CN100594924C Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing the same
03/24/2010CN100594915C Traditional Chinese medicine extractive for treating cardiovascular diseases and method of preparing the same and uses thereof
03/24/2010CN100594913C Medicine combination for curing diabetes and complication thereof and the preparing method and purpose
03/24/2010CN100594795C Fat and oil composition
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2389928C Method for treating diabetes
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2356680C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/18/2010WO2010031061A1 Methods of treatment of hyperuricemia and associated disease states
03/18/2010WO2010031051A1 Methods of treatment of hyperuricemia and associated disease states
03/18/2010WO2010030360A1 3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
03/18/2010WO2010029915A1 Method for producing a composition with a high content of sapogenin
03/18/2010WO2010029461A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010WO2010029191A1 Composition based on conjugated linoleic acid for canned products comprising at least one tuna
03/18/2010WO2010029089A2 Combination therapy for the treatment of diabetes and related conditions
03/18/2010WO2010028981A1 New benzimidazole derivatives
03/18/2010WO2010028676A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent
03/18/2010WO2010028674A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028673A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028672A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028671A1 Use of opiorphin as a therapeutic agent
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2009154697A3 Disc-1 pathway activators in the control of neurogenesis
03/18/2010WO2009134380A8 Super fast-acting insulin compositions
03/18/2010WO2009078012A3 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes
03/18/2010WO2009056707A8 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
03/18/2010US20100069502 Assay
03/18/2010US20100069498 Use of alpha-ketoglutaric acid for the treatment of high plasma glucose condition
03/18/2010US20100069496 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/18/2010US20100069492 Production of ultrapure epa and polar lipids from largely heterotrophic culture
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069478 Isoflavone derivatives and uses thereof
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069460 1-phenyl 1-thio-d-glucitol derivative
03/18/2010US20100069459 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium
03/18/2010US20100069456 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
03/18/2010US20100069454 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069413 Pyrimidine and Quinazoline Derivatives
03/18/2010US20100069388 N-hydroxyacrylamide compounds
03/18/2010US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
03/18/2010US20100069364 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments
03/18/2010US20100069363 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
03/18/2010US20100069362 Thienopyrimidone compound
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069352 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo[5,4-c] pyridin-4-one derivatives and their use as mch receptor antagonists
03/18/2010US20100069351 Spiro compound and use thereof
03/18/2010US20100069349 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069341 Tetrahydro-pyranopyrazole cannabinoid modulators
03/18/2010US20100069335 Prevention and Treatment of Ophthalmic Complications of Diabetes
03/18/2010US20100069327 Nutritional products comprising saccharide oligomers
03/18/2010US20100069310 1-chloro-4-( beta -D-glucopyranos-1-yl)-2-[4-((1R,2R)-2-hydroxy-cyclopent-1-yloxy)-benzyl]-benzene; metabolic disorders such as diabetes, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia; sodium-dependent glucose cotransporter SGLT2 inhibitors
03/18/2010US20100069299 Ghrelin analogs
03/18/2010US20100069293 Polymeric carrier compositions for delivery of active agents, methods of making and using the same
03/18/2010US20100068311 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
03/18/2010US20100068293 Milk ingredient enriched in polar lipids and uses thereof
03/18/2010US20100068289 Spherical microcapsules comprising glp-i peptides, their production and use
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068167 Low Salt Forms of Polyallylamine
03/18/2010CA2737163A1 Methods of treatment of hyperuricemia and associated disease states
03/18/2010CA2736421A1 Combination therapy for the treatment of diabetes and related conditions
03/18/2010CA2736349A1 Pcsk9 antagonists
03/18/2010CA2735184A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2734034A1 New benzimidazole derivatives
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163555A1 New pyrazole derivatives and diabetic medicine containing them
03/17/2010EP2163543A1 Nitrogen-containing heterocyclic derivative having 11 beta-hydroxysteroid dehydrogenase type i inhibitory activity
1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 1298